C. S. Pramesh Has Been Elected UICC President-Elect for the 2026–2028 Term
FDA Grants Accelerated Approval: Dostarlimab for MSI-H/dMMR Locally Advanced Rectal Cancer
A Defining Moment for Cancer Immunotherapy During ESMO 2026 - Agenus
Tattoos and Cancer: Is There a Link to Skin Cancer and Lymphoma?
RASolve 308: Phase III Trial Tests Zoldonrasib With Pembrolizumab and Chemotherapy in First-Line RAS G12D NSCLC
Bari, 1943: The Disaster That Changed Cancer Treatment
Revolution Medicines Begins Phase 3 RASolve 308 Trial of Zoldonrasib in RAS G12D Non-squamous NSCLC
ESMO 2026: 5 Phase III Immunotherapy Trials to Watch
The ALRCaN Global webinar, “Germline Predisposition and Acute Leukemia,” is scheduled for Friday, August 14, 2026, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). Presented […]
